ADMET screening is a crucial process in drug discovery and development, standing for Absorption, Distribution, Metabolism, Excretion, and Toxicity. It involves assessing how a potential drug compound interacts with a living organism, from its entry into the body to its elimination and potential harmful effects. The core mechanism of ADMET screening is to predict these pharmacokinetic and toxicological profiles early in the drug design pipeline, often using computational (in silico) methods, followed by in vitro and sometimes in vivo experiments. This process is vital because poor ADMET properties are a leading cause of drug candidate failure in clinical trials, making early identification of problematic compounds a significant cost and time saver. Researchers and pharmaceutical companies widely use ADMET screening to prioritize promising compounds, optimize their properties, and accelerate the development of safer and more effective therapies, such as in the AI-assisted design of molecular glues for Alzheimer's disease.
ADMET screening is a vital part of drug discovery that predicts how a potential medicine will behave in the body, covering its absorption, distribution, metabolism, excretion, and toxicity. By identifying problems early, it helps scientists develop safer and more effective drugs while saving significant time and money.
ADME-Tox, ADME screening, pharmacokinetic screening, preclinical ADMET
Was this definition helpful?